Opioid use and effectiveness of its prescription at discharge in an acute pain relief and palliative care unit

Antonino Giarratano, Santi Maurizio Raineri, Alessandra Casuccio, Giovanna Prestia, Sebastiano Mercadante

Risultato della ricerca: Article

8 Citazioni (Scopus)

Abstract

The aim of this study was to present how opioidsare used in an acute pain relief and palliative care unit(APRPCU), where many patients with difficult pain conditionsare admitted from GPs, home palliative care programs,oncology departments, other hospitals or emergency units,and other regional places. From a consecutive sample ofcancer patients admitted to an APRPCU for a period of6 months, patients who had been administered opioids wereincluded in this survey. Basic information was collected aswell as opioid therapy prescribed at admission and, subsequently,during admission and at time of discharge. Patientswere discharged once stabilization of pain and symptomswere obtained and the treatment was considered to be optimized.One week after being discharged, patients or relativeswere contacted by phone to gather information aboutthe availability of opioids at dosages prescribed at time ofdischarge. One hundred eighty six of 231 patients werespecifically admitted for uncontrolled pain, with a meanpain intensity of 6.8 (SD 2.5). The mean dose of oralmorphine equivalents in patients receiving opioids beforeadmission was 45 mg/day (range 10–500 mg). One hundredseventy five patients (75.7 %) were prescribed around theclock opioids at admission. About one third of patientschanged treatment (opioid or route). Forty two of 175(24 %), 27/58 (46.5 %), 10/22 (45.4 %), and 2/4 (50 %)patients were receiving more than 200 mg of oral morphineequivalents, as maximum dose of the first, second, third, andfourth opioid prescriptions, respectively. The pattern ofopioids changed, with the highest doses administered withsubsequent line options. The mean final dose of opioids,expressed as oral morphine equivalents, for all patients was318 mg/day (SD 798), that is more than six times the dosesof pre-admission opioid doses. One hundred eighty sixpatients (80.5 %) were prescribed a breakthrough cancerpain (BTcP) medication at admission. Sixty five patientschanged their BTcP prescription, and further 27 patientschanged again. Finally, eight patients were prescribed afourth BTcP medication. Of 46 patients available for interview,the majority of them (n=39, 84 %) did not haveproblems with their GPs, who facilitated prescription andavailability of opioids at the dosages prescribed at discharge.For patients with severe distress, APRPCUs mayguarantee a high-level support to optimize pain and symptomintensities providing intensive approach and resolvinghighly distressing situations in a short time by optimizingthe use of opioids.
Lingua originaleEnglish
pagine (da-a)1853-1859
Numero di pagine7
RivistaSupportive Care in Cancer
Volume21
Stato di pubblicazionePublished - 2013

Fingerprint

Acute Pain
Palliative Care
Opioid Analgesics
Prescriptions
Pain
Hospital Units
Home Care Services
Morphine
Hospital Emergency Service
Therapeutics
Interviews

All Science Journal Classification (ASJC) codes

  • Oncology

Cita questo

@article{e9dee13c3ed44f54bfdefec5309a7385,
title = "Opioid use and effectiveness of its prescription at discharge in an acute pain relief and palliative care unit",
abstract = "The aim of this study was to present how opioidsare used in an acute pain relief and palliative care unit(APRPCU), where many patients with difficult pain conditionsare admitted from GPs, home palliative care programs,oncology departments, other hospitals or emergency units,and other regional places. From a consecutive sample ofcancer patients admitted to an APRPCU for a period of6 months, patients who had been administered opioids wereincluded in this survey. Basic information was collected aswell as opioid therapy prescribed at admission and, subsequently,during admission and at time of discharge. Patientswere discharged once stabilization of pain and symptomswere obtained and the treatment was considered to be optimized.One week after being discharged, patients or relativeswere contacted by phone to gather information aboutthe availability of opioids at dosages prescribed at time ofdischarge. One hundred eighty six of 231 patients werespecifically admitted for uncontrolled pain, with a meanpain intensity of 6.8 (SD 2.5). The mean dose of oralmorphine equivalents in patients receiving opioids beforeadmission was 45 mg/day (range 10–500 mg). One hundredseventy five patients (75.7 {\%}) were prescribed around theclock opioids at admission. About one third of patientschanged treatment (opioid or route). Forty two of 175(24 {\%}), 27/58 (46.5 {\%}), 10/22 (45.4 {\%}), and 2/4 (50 {\%})patients were receiving more than 200 mg of oral morphineequivalents, as maximum dose of the first, second, third, andfourth opioid prescriptions, respectively. The pattern ofopioids changed, with the highest doses administered withsubsequent line options. The mean final dose of opioids,expressed as oral morphine equivalents, for all patients was318 mg/day (SD 798), that is more than six times the dosesof pre-admission opioid doses. One hundred eighty sixpatients (80.5 {\%}) were prescribed a breakthrough cancerpain (BTcP) medication at admission. Sixty five patientschanged their BTcP prescription, and further 27 patientschanged again. Finally, eight patients were prescribed afourth BTcP medication. Of 46 patients available for interview,the majority of them (n=39, 84 {\%}) did not haveproblems with their GPs, who facilitated prescription andavailability of opioids at the dosages prescribed at discharge.For patients with severe distress, APRPCUs mayguarantee a high-level support to optimize pain and symptomintensities providing intensive approach and resolvinghighly distressing situations in a short time by optimizingthe use of opioids.",
author = "Antonino Giarratano and Raineri, {Santi Maurizio} and Alessandra Casuccio and Giovanna Prestia and Sebastiano Mercadante",
year = "2013",
language = "English",
volume = "21",
pages = "1853--1859",
journal = "Supportive Care in Cancer",
issn = "0941-4355",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Opioid use and effectiveness of its prescription at discharge in an acute pain relief and palliative care unit

AU - Giarratano, Antonino

AU - Raineri, Santi Maurizio

AU - Casuccio, Alessandra

AU - Prestia, Giovanna

AU - Mercadante, Sebastiano

PY - 2013

Y1 - 2013

N2 - The aim of this study was to present how opioidsare used in an acute pain relief and palliative care unit(APRPCU), where many patients with difficult pain conditionsare admitted from GPs, home palliative care programs,oncology departments, other hospitals or emergency units,and other regional places. From a consecutive sample ofcancer patients admitted to an APRPCU for a period of6 months, patients who had been administered opioids wereincluded in this survey. Basic information was collected aswell as opioid therapy prescribed at admission and, subsequently,during admission and at time of discharge. Patientswere discharged once stabilization of pain and symptomswere obtained and the treatment was considered to be optimized.One week after being discharged, patients or relativeswere contacted by phone to gather information aboutthe availability of opioids at dosages prescribed at time ofdischarge. One hundred eighty six of 231 patients werespecifically admitted for uncontrolled pain, with a meanpain intensity of 6.8 (SD 2.5). The mean dose of oralmorphine equivalents in patients receiving opioids beforeadmission was 45 mg/day (range 10–500 mg). One hundredseventy five patients (75.7 %) were prescribed around theclock opioids at admission. About one third of patientschanged treatment (opioid or route). Forty two of 175(24 %), 27/58 (46.5 %), 10/22 (45.4 %), and 2/4 (50 %)patients were receiving more than 200 mg of oral morphineequivalents, as maximum dose of the first, second, third, andfourth opioid prescriptions, respectively. The pattern ofopioids changed, with the highest doses administered withsubsequent line options. The mean final dose of opioids,expressed as oral morphine equivalents, for all patients was318 mg/day (SD 798), that is more than six times the dosesof pre-admission opioid doses. One hundred eighty sixpatients (80.5 %) were prescribed a breakthrough cancerpain (BTcP) medication at admission. Sixty five patientschanged their BTcP prescription, and further 27 patientschanged again. Finally, eight patients were prescribed afourth BTcP medication. Of 46 patients available for interview,the majority of them (n=39, 84 %) did not haveproblems with their GPs, who facilitated prescription andavailability of opioids at the dosages prescribed at discharge.For patients with severe distress, APRPCUs mayguarantee a high-level support to optimize pain and symptomintensities providing intensive approach and resolvinghighly distressing situations in a short time by optimizingthe use of opioids.

AB - The aim of this study was to present how opioidsare used in an acute pain relief and palliative care unit(APRPCU), where many patients with difficult pain conditionsare admitted from GPs, home palliative care programs,oncology departments, other hospitals or emergency units,and other regional places. From a consecutive sample ofcancer patients admitted to an APRPCU for a period of6 months, patients who had been administered opioids wereincluded in this survey. Basic information was collected aswell as opioid therapy prescribed at admission and, subsequently,during admission and at time of discharge. Patientswere discharged once stabilization of pain and symptomswere obtained and the treatment was considered to be optimized.One week after being discharged, patients or relativeswere contacted by phone to gather information aboutthe availability of opioids at dosages prescribed at time ofdischarge. One hundred eighty six of 231 patients werespecifically admitted for uncontrolled pain, with a meanpain intensity of 6.8 (SD 2.5). The mean dose of oralmorphine equivalents in patients receiving opioids beforeadmission was 45 mg/day (range 10–500 mg). One hundredseventy five patients (75.7 %) were prescribed around theclock opioids at admission. About one third of patientschanged treatment (opioid or route). Forty two of 175(24 %), 27/58 (46.5 %), 10/22 (45.4 %), and 2/4 (50 %)patients were receiving more than 200 mg of oral morphineequivalents, as maximum dose of the first, second, third, andfourth opioid prescriptions, respectively. The pattern ofopioids changed, with the highest doses administered withsubsequent line options. The mean final dose of opioids,expressed as oral morphine equivalents, for all patients was318 mg/day (SD 798), that is more than six times the dosesof pre-admission opioid doses. One hundred eighty sixpatients (80.5 %) were prescribed a breakthrough cancerpain (BTcP) medication at admission. Sixty five patientschanged their BTcP prescription, and further 27 patientschanged again. Finally, eight patients were prescribed afourth BTcP medication. Of 46 patients available for interview,the majority of them (n=39, 84 %) did not haveproblems with their GPs, who facilitated prescription andavailability of opioids at the dosages prescribed at discharge.For patients with severe distress, APRPCUs mayguarantee a high-level support to optimize pain and symptomintensities providing intensive approach and resolvinghighly distressing situations in a short time by optimizingthe use of opioids.

UR - http://hdl.handle.net/10447/73950

M3 - Article

VL - 21

SP - 1853

EP - 1859

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

SN - 0941-4355

ER -